Project Grant HT94252510546
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$195K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This $682,472 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by the Sanford Burnham Prebys Medical Discovery Institute (SBP) to selectively target mutant SHP2 oncoproteins in rare leukemias. The award will fund SBP's efforts to advance understanding of the fundamental mechanisms of disease and develop innovative therapies, with a focus on areas such as cancer, aging, neurodegenerative...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $571,350.00 in funding to the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, California. The award supports research aimed at developing metabolic interventions to halt the progression of pancreatic cancer. SBP, an independent non-profit biomedical research organization, will leverage advanced technologies and...
The Defense Health Agency awarded a $352,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research. The grant, titled "AUGMENTING IN VIVO EFFICACY OF A NOVEL LANOSTEROL SYNTHASE INHIBITOR IN GLIOBLASTOMA", will support advanced biomedical research to investigate innovative treatments for glioblastoma, a type of brain cancer. The research, spanning from September 2025 to August 2027, aims to...
The federal Project Grant award, valued at $176,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the Sloan-Kettering Institute for Cancer Research in establishing a mouse model of myxoid/round cell liposarcoma with endogenous translocations. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on critical health...
The federal Project Grant award of $974,355.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sanford Burnham Prebys Medical Discovery Institute. The award supports a research project entitled "WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY" with a performance period from July 1, 2024 to June 30, 2027. The funding will enable the Sanford Burnham Prebys Medical Discovery...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $158,254.00 to the University of Illinois to support a research project titled "DUAL CRE/LOX AND LENTIVIRAL CRISPR/CAS9 SYSTEM FOR PRECISE IN VIVO DISSECTION OF GBM AND MICROENVIRONMENT INTERACTION." The project aims to advance scientific understanding and treatment of glioblastoma (GBM) by developing innovative genetic technologies for in...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,710,727.00 in funding to Health Research, Inc. (a non-profit organization) to conduct research on targeting the BRSK2 gene in aggressive breast cancer brain metastasis. The award period runs from Sep 30, 2024 to Sep 29, 2027. As a prime grantee, Health Research, Inc. will leverage its expertise in cancer biology, immunotherapy development, and biomarker...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The federal Project Grant award of $210,292 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma", a project focused on advancing imaging techniques to better understand metabolic changes in brain cancer. The award was granted to The Washington University, a private research institution,...